Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

Mavrakanas T, Bounameaux H.

Pharmacol Ther. 2011 Apr;130(1):46-58. doi: 10.1016/j.pharmthera.2010.12.007. Epub 2010 Dec 24. Review.

PMID:
21185864
2.

New oral anticoagulants in development.

Weitz JI.

Thromb Haemost. 2010 Jan;103(1):62-70. doi: 10.1160/TH09-07-0434. Epub 2009 Oct 26. Review.

PMID:
20062934
3.

Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.

Morell J, Sullivan B, Khalabuda M, McBride BF.

J Clin Pharmacol. 2010 Sep;50(9):986-1000. doi: 10.1177/0091270009355814. Epub 2010 Feb 2.

PMID:
20124518
4.

New anticoagulants: focus on venous thromboembolism.

Gómez-Outes A, Lecumberri R, Pozo C, Rocha E.

Curr Vasc Pharmacol. 2009 Jul;7(3):309-29. Review.

PMID:
19601856
5.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
6.

Old and new anticoagulant drugs: a minireview.

Mannucci PM, Franchini M.

Ann Med. 2011 Mar;43(2):116-23. doi: 10.3109/07853890.2010.539250. Epub 2011 Jan 24. Review.

PMID:
21254900
7.

Current issues in anticoagulation.

Agnelli G.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:2-9. Review.

PMID:
15812198
8.

Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa.

Bauer KA.

J Thromb Haemost. 2011 Jul;9 Suppl 1:12-9. doi: 10.1111/j.1538-7836.2011.04321.x. Review.

9.

Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Baetz BE, Spinler SA.

Pharmacotherapy. 2008 Nov;28(11):1354-73. doi: 10.1592/phco.28.11.1354. Review.

PMID:
18956996
10.

[New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].

Scardi S, Giansante C.

Ital Heart J Suppl. 2004 Sep;5(9):705-11. Review. Italian.

PMID:
15568608
11.

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Scaglione F.

Clin Pharmacokinet. 2013 Feb;52(2):69-82. doi: 10.1007/s40262-012-0030-9. Review.

PMID:
23292752
12.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
14.

Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025. Review.

PMID:
18393143
15.

Factor Xa and thrombin as targets for new oral anticoagulants.

Weitz JI.

Thromb Res. 2011 Jan;127 Suppl 2:S5-S12. doi: 10.1016/S0049-3848(10)70147-X.

PMID:
21193114
16.

Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.

Zikria JC, Ansell J.

Curr Opin Hematol. 2009 Sep;16(5):347-56. doi: 10.1097/MOH.0b013e32832ea2d7.

PMID:
19550318
17.

Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.

Mangiafico RA, Mangiafico M.

Curr Med Chem. 2012;19(27):4688-98. Review.

PMID:
22830344
18.

Newer anticoagulants in cardiovascular disease: a systematic review of the literature.

Maan A, Padmanabhan R, Shaikh AY, Mansour M, Ruskin JN, Heist EK.

Cardiol Rev. 2012 Sep-Oct;20(5):209-21. doi: 10.1097/CRD.0b013e3182503e2d. Review.

PMID:
22370770
19.

Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?

Fareed J, Iqbal O, Cunanan J, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Int Angiol. 2008 Jun;27(3):176-92. Review.

PMID:
18506123
20.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Martí-Fàbregas J, Mateo J.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3. Review.

PMID:
19342840

Supplemental Content

Support Center